Skip to main content

Table 4 Impact of potential confounders on changes in plaque volume following statin therapy in random-effects meta-regression

From: Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies

Confounder

Slope

95 % CI

P value

Age (years)

0.009

−0.020, 0.039

0.537

% Males

−0.011

−0.024, 0.002

0.106

% Diabetics

0.003

−0.002, 0.008

0.255

% Smokers

−0.004

−0.009, 0.0004

0.075

Dose (mg/day)a

−0.007

−0.015, 0.001

0.091

Baseline LDL-C (mg/dL)

0.004

−0.007, 0.016

0.435

  1. aRestricted to atorvastatin trials. CI, confidence interval; LDL-C, low-density lipoprotein cholesterol